BIU-87-luc

BIU-87 Luciferase Cell Line engineered for stable, high-efficiency expression of the luciferase gene.This advanced tool delivers exceptionally high imaging quality and precise, quantifiable luminescence, ensuring your data is both robust and publication-ready.
Designed for versatility, the BIU-87 Luciferase Cell Line seamlessly adapts to a broad spectrum of applications—from promoter activity assays and mammalian two-hybrid studies to sophisticated in vivo imaging.
BIU-87 cell line was established by Yu Lizhang et al. in 1989; it originated from human bladder transitional cell carcinoma of papillary type and are typically inoculated subcutaneously into nude mice with 5×10^8 cells in a 0.2ml inoculation volume. BIU-87 cells exhibit progressive tumor growth, and tumor nodules obtained through pathological examination resemble the cancerous tissue of the original specimen. The population doubling time of the 22nd generation of BIU-87 cells is 34 hours; these cells can grow on soft agar with a colony-forming efficiency of 23%. BIU-87 cells exhibit agglutination reactions to ConA, WGA, and PSL.